Five Stocks To Buy According To Top Biotech-Focused Funds
Biotechnology is a very interesting industry to invest in, but also very complex.
Posts Tagged ‘Partner Fund Management’
13G Filing: Partner Fund Management and Jounce Therapeutics Inc (JNCE)
Please follow Partner Fund Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Partner Fund Management or update its...
13G Filing: Partner Fund Management and Invuity Inc. (IVTY)
Please follow Partner Fund Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Partner Fund Management or update its...
13G Filing: Partner Fund Management and Aerie Pharmaceuticals Inc (AERI)
You can access the original SEC filing by clicking here.
13G Filing: Partner Fund Management and Portola Pharmaceuticals Inc (PTLA)
You can access the original SEC filing by clicking here.
13G Filing: Partner Fund Management and Acorda Therapeutics Inc (ACOR)
You can access the original SEC filing by clicking here.
13G Filing: Partner Fund Management and Coherus Biosciences Inc. (CHRS)
You can access the original SEC filing by clicking here.
13G Filing: Partner Fund Management and Puma Biotechnology Inc. (PBYI)
You can access the original SEC filing by clicking here.
13G Filing: Partner Fund Management and Endologix Inc (ELGX)
You can access the original SEC filing by clicking here.
13G Filing: Partner Fund Management and Medicines Co (MDCO)
You can access the original SEC filing by clicking here.
13G Filing: Partner Fund Management and Pacira Pharmaceuticals Inc (PCRX)
You can access the original SEC filing by clicking here.
13G Filing: Partner Fund Management and Myokardia Inc (MYOK)
You can access the original SEC filing by clicking here.
Partner Fund Management Has Confidence In Blueprint Medicines Corp (BPMC)
Chris James' Partner Fund Management revealed a 5.1% position in Blueprint Medicines Corp (NASDAQ:BPMC) last week.
Microsoft Corporation (MSFT), Valeant Pharmaceuticals Intl Inc (VRX): Partner Fund Management’s Winning Bets in Healthcare and Tech
Headquartered in San Francisco, Partner Fund Management was established in 2004 by Christopher Medlock James.
Point State Capital Boosts its Stake in The Medicines Company (MDCO) to 7%
Led by Sean Cullinan, Point State Capital revealed a significantly increased position in The Medicines Company (NASDAQ:MDCO).
Four Insiders Bullish On Teradata Corporation (TDC)
Teradata Corporation (NYSE:TDC) has witnessed interesting insider activity over the past week. At least four Board Directors acquired stock from the company.
Lone Pine Capital Raised its Stake in Wyndham Worldwide Corporation (WYN)
Steve Mandel’s Lone Pine Capital revealed in a new filing with the Securities and Exchange Commission, that it has upped its holding in Wyndham Worldwide Corporation (NYSE:WYN...
Five Hedge Fund Moves in Healthcare Sector From This Week
The healthcare sector is usually very attractive to investors, since the companies involved in it have a great potential to grow.
Partner Fund Management Ups Stake in Orexigen Therapeutics, Inc. (OREX)
Christopher Medlock James', San Francisco-based, hedge fund Partner Fund Management has raised its position in Orexigen Therapeutics, Inc.
Repros Therapeutics: New Drug Development Stimulates Insider Trading
Repros Therapeutics new drug: Insider Katherine Anderson, Chief Financial Officer at Repros Therapeutics Inc (NASDAQ:RPRX), purchased 1,000 shares of common stock last week at...
What Hedge Funds Think About Kythera Biopharmaceuticals Inc (KYTH)
To the average investor, there are tons of methods market participants can use to track publicly traded companies.
Should You Avoid Host Hotels and Resorts Inc (HST)?
In the 21st century investor’s toolkit, there are dozens of indicators market participants can use to track Mr. Market.
Hedge Funds Are Crazy About Polypore International, Inc. (PPO)
In the financial world, there are a multitude of methods investors can use to track stocks. Some of the best are hedge fund and insider trading interest.
Repros Therapeutics Inc (RPRX): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
To many of your peers, hedge funds are viewed as bloated, outdated financial vehicles of a forgotten age.
Hedge Funds Aren’t Crazy About Bruker Corporation (BRKR) Anymore
In the eyes of many of your fellow readers, hedge funds are perceived as bloated, old financial tools of a period lost to current times.
Hedge Funds Aren’t Crazy About Volcano Corporation (VOLC) Anymore
If you were to ask many market players, hedge funds are viewed as bloated, outdated investment tools of a forgotten age.
Here is What Hedge Funds and Insiders Think About Puma Biotechnology Inc (PBYI)
In today’s marketplace, there are dozens of methods market participants can use to watch the equity markets.
Should You Avoid Orexigen Therapeutics, Inc. (OREX)?
In the financial world, there are a multitude of metrics shareholders can use to watch their holdings.
Hedge Funds Are Selling Universal American Corporation (UAM)
Now, according to many traders, hedge funds are perceived as delayed, outdated financial vehicles of an era lost to time.
AMC Networks Inc (AMCX): Are Hedge Funds Right About This Stock?
In the financial world, there are tons of indicators market participants can use to watch Mr. Market. A duo of the most useful are hedge fund and insider trading movement.
Is BorgWarner Inc. (BWA) Going to Burn These Hedge Funds?
In the eyes of many of your peers, hedge funds are seen as bloated, outdated investment tools of a period lost to current times.
Health Net, Inc. (HNT): Are Hedge Funds Right About This Stock?
Now, according to many market players, hedge funds are assumed to be delayed, old financial vehicles of a forgotten age.
Should You Buy Health Management Associates Inc (HMA)?
At the moment, there are dozens of indicators investors can use to analyze Mr. Market. Two of the most useful are hedge fund and insider trading activity.
Do Hedge Funds and Insiders Love SINA Corp (SINA)?
In the eyes of many of your peers, hedge funds are assumed to be delayed, old financial tools of an era lost to time.
CBRE Group Inc (CBG): Hedge Funds Aren’t Crazy About It, Insider Sentiment Unchanged
If you were to ask many of your peers, hedge funds are perceived as bloated, old financial vehicles of an era lost to time.
Hedge Funds Are Buying Sirona Dental Systems, Inc. (SIRO)
In the eyes of many traders, hedge funds are assumed to be useless, outdated financial tools of a forgotten age.
Informatica Corporation (INFA): Are Hedge Funds Right About This Stock?
To many traders, hedge funds are seen as overrated, outdated financial tools of an era lost to time.
Is Aegerion Pharmaceuticals, Inc. (AEGR) Going to Burn These Hedge Funds?
To the average investor, there are dozens of gauges market participants can use to watch publicly traded companies.
Is Rockwell Automation (ROK) Going to Burn These Hedge Funds?
Now, according to many traders, hedge funds are seen as overrated, old financial vehicles of a forgotten age.
Is Wyndham Worldwide Corporation (WYN) Going to Burn These Hedge Funds?
At the moment, there are a multitude of indicators investors can use to monitor their holdings. A couple of the best are hedge fund and insider trading movement.
Charles Schwab Corp (SCHW): Insiders Are Buying, Should You?
In the 21st century investor’s toolkit, there are a multitude of indicators shareholders can use to analyze their holdings.
What Hedge Funds Think About Medivation Inc (MDVN)
In today’s marketplace, there are a multitude of methods shareholders can use to monitor the equity markets.
This Metric Says You Are Smart to Buy Starwood Hotels & Resorts Worldwide, Inc (HOT)
In today’s marketplace, there are plenty of indicators market participants can use to analyze stocks.
What Hedge Funds and Insiders Think About Citrix Systems, Inc. (CTXS)
To the average investor, there are a multitude of metrics investors can use to analyze their holdings.
Eaton Corporation, PLC Ordinary Shares (ETN): Are Hedge Funds Right About This Stock?
Now, according to many investors, hedge funds are assumed to be overrated, outdated financial tools of a period lost to current times.
Cummins Inc. (CMI): Are Hedge Funds Right About This Stock?
To the average investor, there are tons of indicators shareholders can use to analyze their holdings. Some of the best are hedge fund and insider trading interest.
Someone’s Selling Pfizer Inc. (PFE) Shares, Should You?
Now, according to many traders, hedge funds are seen as delayed, outdated investment tools of an era lost to time.
Yahoo! Inc. (YHOO): Surprisingly, Insiders and Hedge Funds Aren’t Buying
Yahoo! Inc. (NASDAQ:YHOO) has been a trendy pick among many investors, and shares have ballooned in 2013.
Who’s Betting On Gilead Sciences, Inc. (GILD)?
If you were to ask many investors, hedge funds are seen as delayed, old financial vehicles of an era lost to time.
Hertz Global Holdings, Inc. (HTZ): Are Hedge Funds Right About This Stock?
In the 21st century investor’s toolkit, there are dozens of metrics investors can use to analyze stocks.
